|ARCA biopharma, Inc.|
8001 Arista Place
United States - Map
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
|Dr. Michael R. Bristow M.D., Ph.D.,
Co-Founder, Chief Exec. Officer, Pres and Director
|Mr. Patrick M. Wheeler ,
Chief Financial Officer and Principal Accounting Officer
|Mr. Christopher D. Ozeroff ,
Sr. VP, Gen. Counsel and Sec.
|Mr. Thomas A. Keuer ,
Exec. VP of Operations
|Mr. Derek K. Cole ,
VP of Investor Relations and Corp. Communications
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|